arrow_back Trending Legislation
Share share

Modern Mental Health Therapies for Veterans: New Office and Innovative Treatments

The act establishes a dedicated Office of Novel Therapeutics to prepare the veterans' healthcare system for the safe implementation of innovative treatments, such as psychedelic-assisted therapies. These changes aim to provide faster access to modern help for depression, PTSD, and other mental health conditions.
Key points
Establishment of the Office of Novel Therapeutics within the Veterans Health Administration.
Development of standards for new treatment methods, including therapies requiring intensive clinical care.
Creation of a veteran advisory committee to give veterans and their families a voice in care design.
Designation of specialized centers of excellence for research and training in novel therapies.
Ensuring continuity of care through peer support and coordination with community organizations.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Veterans Health Administration Novel Therapeutics Preparedness Act
Print number: S 4220
Sponsor: Sen. Sheehy, Tim [R-MT]
Process start date: 2026-03-26
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Modern Mental Health Therapies for Veterans: New Office and Innovative Treatments

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 4220.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2026-03-26.

What are the main provisions?

Key points include:

  • Establishment of the Office of Novel Therapeutics within the Veterans Health Administration.
  • Development of standards for new treatment methods, including therapies requiring intensive clinical care.
  • Creation of a veteran advisory committee to give veterans and their families a voice in care design.
  • Designation of specialized centers of excellence for research and training in novel therapies.
  • Ensuring continuity of care through peer support and coordination with community organizations.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Sheehy, Tim [R-MT].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-04-13.

Analysis and Potential Impact of S 4220

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health